skip to main
|
skip to sidebar
blogging various things biotech...
Health. Food. Energy.
Friday, January 26, 2007
IND approval
Enzon. HIF-1 alpha
antagonist
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
my other blogs
[nano--><--bio]tech
garagebiotech
Blog Archive
►
2013
(12)
►
May
(1)
►
April
(10)
►
March
(1)
►
2010
(2)
►
February
(1)
►
January
(1)
▼
2007
(124)
►
October
(4)
►
September
(12)
►
July
(2)
►
April
(14)
►
March
(2)
►
February
(42)
▼
January
(48)
More on Biotech Generics and the Democratic Congress
More From India
Tougher Standards for Biotech
Pulmonary Arterial Hypertension
Novartis Patent Case in India
Speeding up Tech Transfer
America's Costliest Drugs
Someone (Other Than You) May Own Your Genes? Say Who?
Dems to Deal with Biotech Generics?
Going To The Dogs
Wyeth, Proteins, and The New Book "Science Business"
Lastly, from the Best of '06
Exxon and Ethanol
Carnival of Biotechnology
More from the Best of '06
More From Hawaii...
Best of '06?
Brown Algae and Skin Cancer
In Clue to Addiction, Brain Injury Halts Smoking
Glaxo Distorted Paxil Data?
Enzon
New Fangled Kids
GM Canola to Kill Frans Fat?
Biotech for Energy Needs
Hawaii Takes a Page from San Diego
Two Biotech IPO's
As states court biotechs...
stem-cell institutes
Stem Cell Storage
Bacteria Harnessed As Micro-Robot Motors
Mapping the Metabolome
The Immigrant Technologist
Science Business: the Promise, the Reality, and th...
Biotech Cost Ceiling?
Are We Prepared for the Biotechnology Revolution?
Nanotechnology Based Medicines Nearing Commerciali...
Europe Behind on Agri Biotech?
Non-Science-Based Labeling
The Economist on The Drug Industry
Lessons From Other Industries
Generic v Generic
IND Allowance
IND approval
Amgen Data Disappoints
Richard Branson to Launch Stem Cell Bank:
Tough to Grow Biotech Locally
Other Genentech News...
Genentech - the anti-dumb!
biosink
Loading...
No comments:
Post a Comment